Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct 11:12:468.
doi: 10.1186/1471-2407-12-468.

Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China

Felipe A Castro  1 , Jill Koshiol, Ann W Hsing, Yu-Tang Gao, Asif Rashid, Lisa W Chu, Ming-Chang Shen, Bing-Shen Wang, Tian-Qua Han, Bai-He Zhang, Shelley Niwa, Kai Yu, Hong Zhang, Stephen Chanock, Gabriella Andreotti
Affiliations

Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China

Felipe A Castro et al. BMC Cancer. .

Abstract

Background: Genetic variants in inflammation-related genes have been associated with biliary stones and biliary tract cancers in previous studies.

Methods: To follow-up on these findings, we examined 35 single nucleotide polymorphism (SNPs) in 5 genes related to inflammation (IL8, NFKBIL, RNASEL, TNF, and VEGFA) in 456 participants with incident biliary tract cancer cases (262 gallbladder, 141 extrahepatic bile duct, 53 ampulla of Vater), 982 participants with biliary stones, and 860 healthy controls in a population-based case-control study in Shanghai, China.

Results: Suggestive associations were observed for SNPs in VEGFA with biliary stones, IL8 with gallbladder and ampulla of Vater cancers, and RNASEL with ampulla of Vater cancer (false discovery rate≤0.2).

Conclusion: These findings provide additional support for the role of inflammation in biliary stones and biliary tract cancer risk and need further validation.

PubMed Disclaimer

References

    1. Randi G, Malvezzi M, Levi F, Ferlay J, Negri E, Franceschi S, La Vecchia C. Epidemiology of biliary tract cancers: an update. Ann Oncol. 2009;20(1):146–159. - PubMed
    1. Hsing A, Rashid A, Devesa S, Fraumeni JJ. In: Cancer Epidemiology and Prevention. Third Edition. Jr DSJF, editor. New York: Oxford University Press, Inc; 2006. Biliary Tract Cancer; pp. 787–800.
    1. Hsing AW, Gao YT, Han TQ, Rashid A, Sakoda LC, Wang BS, Shen MC, Zhang BH, Niwa S, Chen J. et al.Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer. 2007;97(11):1577–1582. doi: 10.1038/sj.bjc.6604047. - DOI - PMC - PubMed
    1. Hsing AW, Gao YT, McGlynn KA, Niwa S, Zhang M, Han TQ, Wang BS, Chen J, Sakoda LC, Shen MC. et al.Biliary tract cancer and stones in relation to chronic liver conditions: A population-based study in Shanghai, China. Int J Cancer. 2007;120(9):1981–1985. doi: 10.1002/ijc.22375. - DOI - PubMed
    1. Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, Ortiz-Conde BA, Goedert JJ, Fraumeni JF Jr, O'Brien TR. et al.Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer. 2008;122(8):1849–1853. - PubMed

Publication types

LinkOut - more resources